Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBITDA ratio is N/A as of 2026-09-12T00:15:33.338Z.
Calculation as of: 2026-09-12T00:15:33.338Z.
Quote observation: 2026-09-11T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 80cbdd18a5d98219c307b65e8d4e20be751cbb45263afce5e8db788dc2e2ae0f
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-10.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
N/A
EV/EBITDA RATIO AVG TTM
13.76x
EV/EBITDA RATIO AVG 3Y
18.49x
EV/EBITDA RATIO AVG 5Y
12.39x
EV/EBITDA RATIO AVG 10Y
12.43x
EV/EBITDA RATIO AVG 15Y
13.13x
EV/EBITDA RATIO AVG 20Y
13.53x
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Gilead Sciences, Inc.
Market Cap
$178.44B
EV/EBITDA Ratio
N/A
TTM Avg
13.76x
3Y Avg
18.49x
5Y Avg
12.39x
Market Cap
$176.43B
EV/EBITDA Ratio
18.73x
TTM Avg
19.13x
3Y Avg
20.63x
5Y Avg
19.24x
Market Cap
$191.26B
EV/EBITDA Ratio
7.85x
TTM Avg
9.45x
3Y Avg
20.10x
5Y Avg
22.32x
Market Cap
$140.64B
EV/EBITDA Ratio
22.54x
TTM Avg
21.35x
3Y Avg
23.29x
5Y Avg
21.62x
Market Cap
$130.82B
EV/EBITDA Ratio
24.88x
TTM Avg
25.25x
3Y Avg
24.48x
5Y Avg
21.35x
Market Cap
$130.41B
EV/EBITDA Ratio
30.16x
TTM Avg
45.91x
3Y Avg
57.80x
5Y Avg
54.07x
Market Cap
$226.62B
EV/EBITDA Ratio
25.25x
TTM Avg
22.06x
3Y Avg
21.66x
5Y Avg
20.94x
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Gilead Sciences, Inc. (GILD) | $178.44B | N/A | 13.76x | 18.49x | 12.39x |
| Abbott Laboratories (ABT)vs › | $176.43B | 18.73x | 19.13x | 20.63x | 19.24x |
| Novo Nordisk A/S (NVO)vs › | $191.26B | 7.85x | 9.45x | 20.10x | 22.32x |
| Pfizer Inc. (PFE)vs › | $157.99B | 10.15x | 9.20x | 13.58x | 11.95x |
| Amgen Inc. (AMGN)vs › | $203.66B | N/A | 15.41x | 16.31x | 15.14x |
| Danaher Corporation (DHR)vs › | $140.64B | 22.54x | 21.35x | 23.29x | 21.62x |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $130.82B | 24.88x | 25.25x | 24.48x | 21.35x |
| Intuitive Surgical, Inc. (ISRG)vs › | $130.41B | 30.16x | 45.91x | 57.80x | 54.07x |
| Thermo Fisher Scientific Inc. (TMO)vs › | $226.62B | 25.25x | 22.06x | 21.66x | 20.94x |
| Bristol-Myers Squibb Company (BMY)vs › | $130.00B | 9.71x | 8.46x | 8.07x | 8.70x |
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBITDA RATIO |
|---|---|
| 2026-09-10 | 356.88x |
| 2026-09-09 | 358.72x |
| 2026-09-08 | 360.88x |
| 2026-09-04 | 370.40x |
| 2026-09-03 | 370.88x |
| 2026-09-02 | 367.37x |
| 2026-09-01 | 368.04x |
| 2026-08-31 | 360.22x |
| 2026-08-28 | 358.78x |
| 2026-08-27 | 365.73x |
| 2026-08-26 | 364.05x |
| 2026-08-25 | 365.53x |
| 2026-08-24 | 361.10x |
| 2026-08-21 | 359.74x |
| 2026-08-20 | 353.89x |
| 2026-08-19 | 362.98x |
| 2026-08-18 | 353.89x |
| 2026-08-17 | 344.02x |
| 2026-08-14 | 342.79x |
| 2026-08-13 | 342.31x |
| 2026-08-12 | 337.35x |
| 2026-08-11 | 337.13x |
| 2026-08-10 | 331.21x |
| 2026-08-07 | 331.54x |
| 2026-08-06 | 12.64x |
| 2026-08-05 | 12.72x |
| 2026-08-04 | 13.03x |
| 2026-08-03 | 12.67x |
| 2026-07-31 | 12.59x |
| 2026-07-30 | 12.68x |
| 2026-07-29 | 12.81x |
| 2026-07-28 | 12.95x |
| 2026-07-27 | 12.61x |
| 2026-07-24 | 12.51x |
| 2026-07-23 | 12.64x |
| 2026-07-22 | 12.60x |
| 2026-07-21 | 12.59x |
| 2026-07-20 | 12.85x |
| 2026-07-17 | 12.95x |
| 2026-07-16 | 13.13x |
| 2026-07-15 | 12.72x |
| 2026-07-14 | 12.57x |
| 2026-07-13 | 12.69x |
| 2026-07-10 | 12.55x |
| 2026-07-09 | 13.00x |
| 2026-07-08 | 13.08x |
| 2026-07-07 | 13.13x |
| 2026-07-06 | 12.53x |
| 2026-07-02 | 12.68x |
| 2026-07-01 | 12.21x |
| 2026-06-30 | 12.24x |
| 2026-06-29 | 12.24x |
| 2026-06-26 | 12.38x |
| 2026-06-25 | 12.02x |
| 2026-06-24 | 12.14x |
| 2026-06-23 | 12.13x |
| 2026-06-22 | 12.11x |
| 2026-06-18 | 12.01x |
| 2026-06-17 | 12.16x |
| 2026-06-16 | 12.32x |
| 2026-06-15 | 12.06x |
| 2026-06-12 | 12.18x |
| 2026-06-11 | 12.20x |
| 2026-06-10 | 11.81x |
| 2026-06-09 | 12.17x |
| 2026-06-08 | 12.40x |
| 2026-06-05 | 12.49x |
| 2026-06-04 | 12.50x |
| 2026-06-03 | 12.48x |
| 2026-06-02 | 12.35x |
| 2026-06-01 | 12.67x |
| 2026-05-29 | 12.96x |
| 2026-05-28 | 13.12x |
| 2026-05-27 | 12.90x |
| 2026-05-26 | 12.90x |
| 2026-05-22 | 12.96x |
| 2026-05-21 | 12.61x |
| 2026-05-20 | 12.63x |
| 2026-05-19 | 12.61x |
| 2026-05-18 | 12.54x |
| 2026-05-15 | 12.53x |
| 2026-05-14 | 12.75x |
| 2026-05-13 | 12.84x |
| 2026-05-12 | 13.01x |
| 2026-05-11 | 12.88x |
| 2026-05-08 | 12.69x |
| 2026-05-07 | 13.44x |
| 2026-05-06 | 13.65x |
| 2026-05-05 | 13.39x |
| 2026-05-04 | 13.32x |
| 2026-05-01 | 13.23x |
| 2026-04-30 | 13.15x |
| 2026-04-29 | 12.97x |
| 2026-04-28 | 13.01x |
| 2026-04-27 | 12.87x |
| 2026-04-24 | 13.11x |
| 2026-04-23 | 13.41x |
| 2026-04-22 | 13.34x |
| 2026-04-21 | 13.37x |
| 2026-04-20 | 13.61x |
| 2026-04-17 | 13.77x |
| 2026-04-16 | 13.85x |
| 2026-04-15 | 13.96x |
| 2026-04-14 | 14.03x |
| 2026-04-13 | 13.90x |
| 2026-04-10 | 13.89x |
| 2026-04-09 | 14.17x |
| 2026-04-08 | 14.12x |
| 2026-04-07 | 13.88x |
| 2026-04-06 | 14.00x |
| 2026-04-02 | 13.96x |
| 2026-04-01 | 14.01x |
| 2026-03-31 | 13.93x |
| 2026-03-30 | 13.65x |
| 2026-03-27 | 13.46x |
| 2026-03-26 | 13.70x |
| 2026-03-25 | 13.83x |
| 2026-03-24 | 13.81x |
| 2026-03-23 | 13.74x |
| 2026-03-20 | 13.73x |
| 2026-03-19 | 14.09x |
| 2026-03-18 | 14.10x |
| 2026-03-17 | 14.38x |
| 2026-03-16 | 14.46x |
| 2026-03-13 | 14.44x |
| 2026-03-12 | 14.46x |
| 2026-03-11 | 14.53x |
| 2026-03-10 | 14.76x |
| 2026-03-09 | 14.59x |
| 2026-03-06 | 14.34x |
| 2026-03-05 | 14.45x |
| 2026-03-04 | 14.73x |
| 2026-03-03 | 14.70x |
| 2026-03-02 | 14.90x |
| 2026-02-27 | 14.80x |
| 2026-02-26 | 14.33x |
| 2026-02-25 | 14.63x |
| 2026-02-24 | 15.30x |
| 2026-02-23 | 15.50x |
| 2026-02-20 | 15.65x |
| 2026-02-19 | 15.62x |
| 2026-02-18 | 15.78x |
| 2026-02-17 | 16.02x |
| 2026-02-13 | 15.99x |
| 2026-02-12 | 15.69x |
| 2026-02-11 | 16.07x |
| 2026-02-10 | 15.26x |
| 2026-02-09 | 15.68x |
| 2026-02-06 | 15.75x |
| 2026-02-05 | 15.46x |
| 2026-02-04 | 15.16x |
| 2026-02-03 | 14.88x |
| 2026-02-02 | 14.85x |
| 2026-01-30 | 14.76x |
| 2026-01-29 | 14.53x |
| 2026-01-28 | 14.55x |
| 2026-01-27 | 14.66x |
| 2026-01-26 | 14.36x |
| 2026-01-23 | 14.19x |
| 2026-01-22 | 13.73x |
| 2026-01-21 | 13.54x |
| 2026-01-20 | 13.07x |
| 2026-01-16 | 13.14x |
| 2026-01-15 | 12.80x |
| 2026-01-14 | 13.07x |
| 2026-01-13 | 12.85x |
| 2026-01-12 | 12.93x |
| 2026-01-09 | 12.78x |
| 2026-01-08 | 12.74x |
| 2026-01-07 | 13.09x |
| 2026-01-06 | 12.81x |
| 2026-01-05 | 12.52x |
| 2026-01-02 | 12.83x |
| 2025-12-31 | 12.94x |
| 2025-12-30 | 12.98x |
| 2025-12-29 | 13.14x |
| 2025-12-26 | 13.12x |
| 2025-12-24 | 13.22x |
| 2025-12-23 | 13.17x |
| 2025-12-22 | 13.07x |
| 2025-12-19 | 13.09x |
| 2025-12-18 | 12.82x |
| 2025-12-17 | 12.81x |
| 2025-12-16 | 12.56x |
| 2025-12-15 | 12.66x |
| 2025-12-12 | 12.72x |
| 2025-12-11 | 12.98x |
| 2025-12-10 | 12.81x |
| 2025-12-09 | 12.62x |
| 2025-12-08 | 12.79x |
| 2025-12-05 | 12.80x |
| 2025-12-04 | 12.93x |
| 2025-12-03 | 13.15x |
| 2025-12-02 | 13.05x |
| 2025-12-01 | 13.09x |
| 2025-11-28 | 13.23x |
| 2025-11-26 | 13.39x |
| 2025-11-25 | 13.35x |
| 2025-11-24 | 13.18x |
| 2025-11-21 | 13.31x |
| 2025-11-20 | 13.15x |
| 2025-11-19 | 13.44x |
| 2025-11-18 | 13.36x |
| 2025-11-17 | 13.07x |
| 2025-11-14 | 13.16x |
| 2025-11-13 | 13.17x |
| 2025-11-12 | 13.00x |
| 2025-11-11 | 12.92x |
| 2025-11-10 | 12.51x |
| 2025-11-07 | 15.61x |
| 2025-11-06 | 16.14x |
| 2025-11-05 | 16.05x |
| 2025-11-04 | 16.10x |
| 2025-11-03 | 15.99x |
| 2025-10-31 | 15.72x |
| 2025-10-30 | 15.57x |
| 2025-10-29 | 15.57x |
| 2025-10-28 | 15.50x |
| 2025-10-27 | 15.80x |
| 2025-10-24 | 15.86x |
| 2025-10-23 | 15.83x |
| 2025-10-22 | 15.92x |
| 2025-10-21 | 16.22x |
| 2025-10-20 | 16.11x |
| 2025-10-17 | 16.07x |
| 2025-10-16 | 15.50x |
| 2025-10-15 | 15.55x |
| 2025-10-14 | 15.57x |
| 2025-10-13 | 15.54x |
| 2025-10-10 | 15.42x |
| 2025-10-09 | 15.37x |
| 2025-10-08 | 15.54x |
| 2025-10-07 | 15.37x |
| 2025-10-06 | 15.00x |
| 2025-10-03 | 14.90x |
| 2025-10-02 | 14.65x |
| 2025-10-01 | 14.72x |
| 2025-09-30 | 14.70x |
| 2025-09-29 | 14.89x |
| 2025-09-26 | 14.83x |
| 2025-09-25 | 14.70x |
| 2025-09-24 | 15.01x |
| 2025-09-23 | 15.10x |
| 2025-09-22 | 14.88x |
| 2025-09-19 | 15.06x |
| 2025-09-18 | 15.01x |
| 2025-09-17 | 14.85x |
| 2025-09-16 | 14.69x |
| 2025-09-15 | 14.88x |
| 2025-09-12 | 15.12x |
| 2025-09-11 | 15.50x |
| 2025-09-10 | 15.20x |
| 2025-09-09 | 15.26x |
| 2025-09-08 | 15.27x |
| 2025-09-05 | 15.17x |
| 2025-09-04 | 14.91x |
| 2025-09-03 | 14.93x |
| 2025-09-02 | 14.90x |
| 2025-08-29 | 14.93x |
| 2025-08-28 | 14.88x |
Showing the most recent 260 of 4,857 data points. The chart above shows the full history.
